Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aim Immunotech Inc (NY: AIM )

0.2190 +0.0060 (+2.82%)
Official Closing Price Updated: 8:00 PM EST, Dec 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 307,652
Open 0.2129
Bid (Size) 0.2050 (19)
Ask (Size) 0.2190 (44)
Prev. Close 0.2130
Today's Range 0.2015 - 0.2200
52wk Range 0.1628 - 0.6200
Shares Outstanding 4,020,334
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AIM ImmunoTech Urges Shareholders to Vote on the WHITE Universal Proxy Card “FOR” All Four Incumbent Board Members
From AIM ImmunoTech Inc.
Via Business Wire
Glass Lewis Recommends AIM ImmunoTech Shareholders Vote “FOR” Company Nominees Nancy K. Bryan, Thomas K. Equels and Dr. William M. Mitchell
From AIM ImmunoTech Inc.
Via Business Wire

Performance

YTD
-53.89%
-53.89%
1 Month
-9.50%
-9.50%
3 Month
-26.24%
-26.24%
6 Month
-51.22%
-51.22%
1 Year
-58.29%
-58.29%

More News

Read More
ISS Recommends AIM ImmunoTech Shareholders Vote “FOR” Company Nominees Nancy K. Bryan and Dr. William M. Mitchell
From AIM ImmunoTech Inc.
Via Business Wire
AIM ImmunoTech Issues Presentation Detailing Why Shareholders Should NOT Elect Activist Group’s Nominees to the Board
From AIM ImmunoTech Inc.
Via Business Wire
Insights into AIM ImmunoTech's Upcoming Earnings
Via Benzinga
Exploring AIM ImmunoTech's Earnings Expectations
Via Benzinga
AIM Stock Earnings: AIM ImmunoTech Misses EPS for Q1 2024
Via InvestorPlace
AIM ImmunoTech Refutes Activist Group’s False and Misleading Claims
From AIM ImmunoTech Inc.
Via Business Wire
AIM ImmunoTech Announces Cash Conservation Plan
From AIM ImmunoTech Inc.
Via Business Wire
AIM ImmunoTech Issues Presentation Detailing Case for Re-Electing Current Directors to Oversee Continued Momentum and Drive Strategy to Create Long-Term Value for Patients and Shareholders
From AIM ImmunoTech Inc.
Via Business Wire
Earnings Scheduled For November 15, 2024
Via Benzinga
Preview: AIM ImmunoTech's Earnings
Via Benzinga
AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders
From AIM ImmunoTech Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
AIM Stock Earnings: AIM ImmunoTech Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
AIM Stock Earnings: AIM ImmunoTech Misses EPS, Beats Revenue for Q4 2023
Via InvestorPlace
Earnings Scheduled For April 2, 2024
Via Benzinga
Earnings Scheduled For March 26, 2024
Via Benzinga
AIM ImmunoTech And 3 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
AIM Shareholders Elect All Four Company Director Nominees at 2023 Annual Meeting
From AIM ImmunoTech Inc.
Via Business Wire
Delaware Court Rules in Favor of AIM ImmunoTech and Upholds Board’s Determination that Activist Group’s Nominations Are Invalid
From AIM ImmunoTech Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.